Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium

BACKGROUND: Genital psoriasis remains underdiagnosed and undertreated despite its substantial impact on quality of life. The sensitive nature of genital involvement contributes to diagnostic delays, patient distress, and treatment challenges. The Genital Psoriasis Wellness Consortium, a multidisciplinary panel of US-based clinicians, previously developed consensus statements on physical diagnosis, patient conversations, quality of life impacts, and treatment. OBJECTIVE: We aimed to build on prior work by providing additional considerations to refine best practices across three areas: physical exam and diagnosis; pediatric and adolescent treatment; and adult and geriatric treatment. METHODS: The panel used the modified Delphi process and nominal group technique, informed by a systematic literature review, with consensus defined as ≥ 75% agreement on a 7-point Likert scale. RESULTS: The panel emphasized routine genital assessment within comprehensive skin exams and proactive empathetic communication to reduce stigma, with verbal consent and the offer of a chaperone as standard practice. In pediatric care, shared decision making among clinicians, caregivers, and patients fosters adherence. In adults and older patients, treatment decisions should consider comorbidities, polypharmacy, and individual goals; prioritizing therapies with established safety in intertriginous areas and minimizing long-term corticosteroid use. Simple regimens and attention to access barriers were identified as important to support adherence. CONCLUSIONS: These considerations aim to enhance diagnosis, optimize treatment, and improve outcomes through personalized empathetic care.

Authors

Institutions

Publication Details

Journal
American Journal of Clinical Dermatology
Published
2026-05-13
DOI
https://doi.org/10.1007/s40257-026-01035-0
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium

Muriel Boreham, John G. Zampella, Tina Bhutani, Michael Payette et al.
American Journal of Clinical Dermatology
Psoriasis: Treatment and Pathogenesis
article

Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium

Muriel Boreham, John G. Zampella, Tina Bhutani, Michael Payette, Jennifer Cather, Melissa S. Seal, Richard Fried, Shehla Admani, Lucinda Whitney, Tiffany Mayo, John Koo, Krista Bohnert, Sandra Johnson, Melodie Young, Jeannette Jakus, Diane Hanna
article en

Abstract

BACKGROUND: Genital psoriasis remains underdiagnosed and undertreated despite its substantial impact on quality of life. The sensitive nature of genital involvement contributes to diagnostic delays, patient distress, and treatment challenges. The Genital Psoriasis Wellness Consortium, a multidisciplinary panel of US-based clinicians, previously developed consensus statements on physical diagnosis, patient conversations, quality of life impacts, and treatment. OBJECTIVE: We aimed to build on prior work by providing additional considerations to refine best practices across three areas: physical exam and diagnosis; pediatric and adolescent treatment; and adult and geriatric treatment. METHODS: The panel used the modified Delphi process and nominal group technique, informed by a systematic literature review, with consensus defined as ≥ 75% agreement on a 7-point Likert scale. RESULTS: The panel emphasized routine genital assessment within comprehensive skin exams and proactive empathetic communication to reduce stigma, with verbal consent and the offer of a chaperone as standard practice. In pediatric care, shared decision making among clinicians, caregivers, and patients fosters adherence. In adults and older patients, treatment decisions should consider comorbidities, polypharmacy, and individual goals; prioritizing therapies with established safety in intertriginous areas and minimizing long-term corticosteroid use. Simple regimens and attention to access barriers were identified as important to support adherence. CONCLUSIONS: These considerations aim to enhance diagnosis, optimize treatment, and improve outcomes through personalized empathetic care.

American Journal of Clinical Dermatology
Central Methodist University (US), University of Arkansas – Fort Smith (US), University of Kansas (US), SUNY Downstate Health Sciences University (US), Baylor University Medical Center (US), University of Alabama at Birmingham (US), University of California San Francisco Medical Center (US), Moscow University «Synergy» (RU), Synergy Health (US), Stanford Medicine (US), Atara Biotherapeutics (United States) (US), New York University (US)
Amgen, National Psoriasis Foundation, Eli Lilly and Company, Pfizer, Sanofi, University of Pennsylvania, Regeneron Pharmaceuticals, Dermira, Incyte, Celltrion, Ortho Dermatologics, Concert Pharmaceuticals, Castle Biosciences, Galderma, Sun Pharma, LEO Pharma
Openalex Percentile: Top 8%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.